Immunology and immunity studied with viruses

CIBA Foundation Symposia

Volumn , Issue 204, 1997, Pages 105-129

  Zinkernagel, Rolf M ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; VIRUS ANTIGEN;

ANIMAL; ANTIBODY SPECIFICITY; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HUMAN; IMMUNITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE DEPLETION; PHYSIOLOGY; REVIEW; T LYMPHOCYTE; VACCINATION; VIRUS;

ANIMALS; ANTIBODY SPECIFICITY; ANTIGEN-PRESENTING CELLS; ANTIGENS, VIRAL; B-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNITY; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; LYMPHOCYTE DEPLETION; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION; VIRUSES;

EID: 0030642220     PISSN: 03005208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (167)

1. Ada G 1990 The immunological principles of vaccination. Lancet 335:523-526
2. Ada G 1991 Vaccine development: real and imagined dangers. Nature 349:369
3. Allen PM, Zinkernagel RM 1994 Promethean viruses? Nature 369:355-356
4. Althage A, Odermatt B, Moskophidis D et al 1992 Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation. Eur J Immunol 22:1803-1812
5. Alwan WH, Kozlowska WJ, Openshaw PJM 1994 Distinct types of lung disease caused by functional subsets of antiviral T cells. J Exp Med 179:81-89
6. Ando K, Moriyama T, Guidotti LG et al 1993 Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 178:1541-1554
7. Bachmann MF, Hoffmann Rohrer U, Kündig TM, Bürki K, Hengartner H, Zinkernagel RM 1993 The influence of antigen organisation on B cell responsiveness. Science 262:1448-1451
8. Bachmann MF, Kündig TM, Freer G et al 1994 Induction of protective cytotoxic T cells with viral proteins. Eur J Immunol 24:2128-2236
9. Battegay M, Oehen S, Schulz M, Hengartner H, Zinkernagel RM 1992 Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus mediated immunopathology. J Virol 66:1199-1201
10. Battegay M, Moskophidis D, Waldner H et al 1993a Impairment and delay of neutralizing antiviral antibody responses by virus specific cytotoxic T cells. J Immunol 151:5408-5415
11. Battegay M, Kyburz D, Hengartner H, Zinkernagel RM 1993b Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells. Eur J Immunol 23:3236-3241
12. Behbehani AM 1983 The smallpox story: life and death of an old disease. Microbiol Rev 47:455-509
13. Berek C, Milstein C 1987 Mutation drift and repertoire shift in the maturation of the immune response. Immunol Rev 96:23-41
14. Bertoletti A, Sette A, Chisari FV et al 1994 Natural variants of cytotoxic epitopes are T cell receptor antagonists for anti-viral cytotoxic T cells. Nature 369:407-410
15. Bianchi L 1981 The immunopathology of acute type B hepatitis. Springer Semin Immunopathol 3:421-438
16. Blanden RV 1974 T cell response to viral and bacterial infection. Transplant Rev 19:56-84
17. Brambell RWR 1970 The transmission of immunity from mother to young. North Holland Publishing, Amsterdam
18. Bretscher P, Cohn M 1970 A theory of self-nonself discrimination. Science 169:1042-1049
19. Bucchini D, Reynaud CA, Ripoche MA, Grimal H, Jami J, Weill JC 1987 Rearrangement of a chicken immunoglobulin gene occurs in the lymphoid lineage of transgenic mice. Nature 326:409-411
20. Camp RL, Kraus TA, Birkeland ML, Puré E 1991 High levels of CD44 expression distinguish virgin from antigen-primed B cells. J Exp Med 173:763-766
21. Cannon MJ, Openshaw PJ, Askonas BA 1988 Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J Exp Med 168:1163-1168
22. Castelmur I, DiPaolo C, Bachmann MF, Hengartner H, Zinkernagel RM, Kündig TM 1993 Comparison of the sensitivity of in vivo and in vitro assays for detection of antiviral cytotoxic T cell activity. Cell Immunol 151:460-466
23. Cerny A, Heusser C, Sutter S et al 1986 Generation of agammaglobulinaemic mice by prenatal and postnatal exposure to polyclonal or monoclonal anti-IgM antibodies. Scand J Immunol 24:437-445
24. Charan S, Hengartner H, Zinkernagel RM 1987 Antibodies against the two serotypes of vesicular stomatitis virus measured by enzyme-linked immunosorbent assay: immunodominance of serotype-specific determinants and induction of asymmetrically cross-reactive antibodies. J Virol 61:2509-2514
25. Chen C, Roberts VA, Rittenberg MB 1992 Generation and analysis of random point mutations in an antibody CDR2 sequence: many mutated antibodies lose their ability to bind antigen. J Exp Med 176:855-866
26. Chothia C, Lesk AM, Tramontano A et al 1989 Conformations of immunoglobulin hypervariable regions. Nature 342:877-883
27. Claflin JL, Berry J 1988 Genetics of the phosphocholine-specific antibody response to Streptococcus pneumoniae. Germ-line but not mutated T15 antibodies are dominantly selected. J Immunol 141:4012-4019
28. Cohn M, Langman RE 1990 The Protecton: the unit of humoral immunity selected by evolution Immunol Rev 115:7-147
29. Coutelier J-P, Van der Logt JTM, Heessen FWA, Warnier G, Van Snick JV 1987 IgG2a restriction of murine antibodies elicited by viral infections. J Exp Med 165:64-69
30. Coutelier J-P, Van der Logt JTM, Heessen FWA, Van Snick J 1988 Virally induced modulation of murine IgG antibody subclasses. J Exp Med 168:2373-2378
31. + population. Science 260:98-100
32. Dietzschold B, Ertl HC 1991 New developments in the pre- and post-exposure treatment of rabies. CRC Crit Rev Immunol 10:427-439
33. Dintzis RZ, Middleton MH, Dintzis HM 1983 Studies on the immunogenicity and tolerogenicity of T-independent antigens. J Immunol 131:2196-2203
34. + T lymphocytes. Immunol Today 11:55-59
35. Dulbecco R, Vogt M, Strickland A 1956 A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus. Virology 2:162-205
36. Ehrlich P 1882 Ueber Immunität durch Vererbung und Säugung. Z Hyg Infektionskr 12:183
37. Eisen HN, Siskind GW 1964 Variations in affinities of antibodies during the immune response. Biochemistry 3:996-1008
38. Evavold BD, Allen PM 1991 Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252:1308-1310
39. Fazekas de St Groth S 1967 Cross recognition and cross-reactivity. Cold Spring Harbor Symp Quant Biol 32:525-536
40. Fazekas de St Groth S 1981 The joint evolution of antigens and antibodies. In: Steinberg CM, Lefkovitz I (eds) The immune system, vol 2. Karger, Basel, p155-168
41. Feldmann M, Nossal GJV 1972 Tolerance, enhancement and the regulation of interactions between T cells, B cells and macrophages. Immunol Rev 13:3-34
42. Fields BN 1990 Fields virology, 2nd edn. Raven, New York
43. Freund J, Stern ER, Pisani TM 1947 Isoallergic encephalomyelitis and radiculitis in guinea pigs after one injection of brain and mycobacteria in water-in-oil emulsion. J Immunol 57:179-194
44. Germain RN 1994 MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287-299
45. Goodnow CC, Adelstein S, Basten A 1990 The need for central and peripheral tolerance in the B cell repertoire. Science 248:1373-1379
46. Gray D, Matzinger P 1991 T cell memory is short-lived in the absence of antigen. J Exp Med 174:969-974
47. Gray D, Skarvall H 1988 B-cell memory is short-lived in the absence of antigen. Nature 336:70-73
48. Gray D, Sprent J 1990 Immunological memory. Curr Topics Microbiol Immunol 159:1-138
49. Gresser I, Tovey MG, Maury C, Bandu M-T 1976 Role of interferon in the pathogenesis of virus diseases as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease and influenza viruses. J Exp Med 144:1316-1323
50. Halstead SB 1988 Pathogenesis of dengue: challenges to molecular biology. Science 239:476-481
51. Held W, Shakhov AN, Waanders G et al 1992 An exogenous mouse mammary tumor virus with properties of Mis-1a (Mtv-7). J Exp Med 175:1623-1633
52. Hotchin J 1971 Persistent and slow virus infections. Monogr Virol 3:1-211
53. + T-cell memory determined by clonal burst size. Nature 369:652-654
54. Huang S, Hendriks W, Althage A et al 1993 Immune response in mice that lack the interferon-γ receptor. Science 259:1742-1745
55. Isaacs A, Lindenmann J 1957 Virus interference. 1. The Interferon. Proc R Soc Lond B Biol Sci 147:258-267
56. Jacobs RP, Cole GA 1976 Lymphocytic choriomeningitis virus-induced immunosuppression: a virus-induced macrophage defect. J Immunol 117:1004-1009
57. Jamieson BD, Somasundaram T, Ahmed R 1991 Abrogation of tolerance to a chronic viral infection. J Immunol 147:3521-3529
58. Janeway CA 1989 Approaching the asymptote? Cold Spring Harbor Symp Quant Biol 54:1-13
59. Kägi D, Ledermann B, Bürki K et al 1994a Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31-37
60. Kägi D, Vignaux F, Ledermann B et al 1994b Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528-530
61. Kägi D, Seiter P, Pavlovic J et al 1995 The roles of perforin and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol 25:3256-3262
62. Klenerman P, Rowland-Jones S, McAdam S et al 1994 Cytotoxic T cell activity antagonized by naturally-occurring HIV-1 GAG variants. Nature 369:403-407
63. Klenk H-D, Rott R 1988 Biology of influenza virus pathogenicity. Adv Virus Res 34:247-281
64. Kohler M, Rüttner B, Cooper S, Hengartner H, Zinkernagel RM 1990 Enhanced tumor susceptibility of immunocompetent mice infected with lymphocytic choriomeningitis virus. Cancer Immunol Immunother 32:117-124
65. Kohler P, Trembath J, Merrill DA, Singleton JW, Dubois RS 1974 Immunotherapy with antibody, lymphocytes and transfer factor in chronic hepatitis B. Clin Immunol Immunopathol 2:465-471
66. Kündig TM, Hengartner H, Zinkernagel RM 1993 T cell dependent IFN-γ exerts an antiviral effect in the central nervous system but not in peripheral solid organs. J Immunol 150:2316-2321
67. Kündig TM, Bachmann MF, Ohashi PS, Pircher HP, Hengartner H, Zinkernagel RM 1996 On T cell memory: arguments for antigen dependence. Immunol Rev 150:63-90
68. Lafferty K, Woolnough J 1977 The origin and mechanism of allograft reaction. Immunol Rev 35:231-262
69. Lafferty KJ, Cunningham AJ 1975 A new analysis of allogeneic interactions. Aust J Exp Biol Med Sci 53:27-42
70. Langman RE 1972 The occurrence of antigenic determinants common to flagella of different salmonella strains. Eur J Immunol 2:582-586
71. Langman RE 1989 The immune system. Academic Press, New York
72. Lau LL, Jamieson BD, Somasundaram T, Ahmed R 1994 Cytotoxic T-cell memory without antigen. Nature 369:648-652
73. Lawrence HW 1959 Homograft sensitivity. An expression of the immunologic origins and consequences of individuality. Physiol Rev 39:811-859
74. Lehmann-Grube F 1971 Lymphocytic choriomeningitis virus. Virol Monogr 10:1-173
75. Lehmann-Grube F, Moskophidis D, Löhler J 1988 Recovery from acute virus infection: role of cytotoxic lymphocytes T in the elimination of lymphocytic choriomeningitis virus from spleens of mice. Ann N Y Acad Sci 532:238-256
76. Leist TP, Rüedi E, Zinkernagel RM 1988 Virus-triggered immune suppression in mice caused by virus-specific cytotoxic T cells. J Exp Med 167:1749-1754
77. Levy JA 1988 Mysteries of HIV: challenges for therapy and prevention. Nature 333:519-522
78. Levy JP, Leclerc JC 1977 The murine sarcoma virus-induced tumor: exception or general model in tumor immunology? Adv Cancer Res 24:1-66
79. Liang S, Mozdzanowska K, Palladino G, Gerhard W 1994 Heterosubtypic immunity to influenza type A virus in mice. J Immunol 152:1653-1661
80. Lilly F 1972 Mouse leukemia: a model of a multiple-gene disease. J Nat Cancer Inst 49:927
81. Lilly F, Boyse EA, Old LJ 1964 Genetic basis of susceptibility to viral leukemogenesis. Lancet 11:1207-1209
82. Linton P-J, Decker DJ, Klinman NR 1989 Primary antibody-forming cells and secondary B cells are generated from separate precursor cell subpopulations. Cell 59:1049-1059
83. Macatonia SE, Taylor PM, Knight SC, Askonas BA 1989 Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med 169:1255-1264
84. Marrack P, Kappler J 1994 Subversion of the immune system by pathogens. Cell 76:323-332
85. Martz E, Howell DM 1989 CTL: virus control cells first and cytolytic cells second? DNA fragmentation, apoptosis and the prelytic halt hypothesis. Immunol Today 10:79-86
86. Matsui K, Boniface JJ, Reay PA, Schild H, Fazekas de St Groth B, Davis MM 1991 Low affinity interaction of peptide-MHC complexes with T cell receptors. Science 254:1788-1791
87. Matzinger P, Bevan MJ 1977 Induction of H-2-restricted cytotoxic T cells: in vivo induction has the appearance of being unrestricted. Cell Immunol 33:92-100
88. McIntosh K 1990 Diagnostic virology. In: Fields BN, Knipe DM (eds) Fields virology, 2nd edn. Raven, New York, p 411-440
89. McMichael AJ, Gotch FM, Dongworth DW, Clark A, Potter C1983 Declining T cell immunity to influenza 1977-1982. Lancet II:762-764
90. Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A 1990 Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci USA 87:6599-6603
91. Miller G 1990 Epstein-Barr virus. In: Fields BN, Knipe DM (eds) Fields virology, 2nd edn. Raven, New York, p 1921-1958
92. Mims CA 1987 Pathogenesis of infectious disease. Academic Press, London
93. Mims CA, Wainwright S 1968 The immunodepressive action of lymphocytic choriomeningitis virus in mice. J Immunol 101:717-724
94. Mitchison NA 1964 Induction of immunological paralysis in two zones of dosage. Roy Soc Proc 161:275-292
95. Mondelli M, Eddleston AL 1984 Mechanisms of liver cell injury in acute and chronic hepatitis. Semin Liver Dis 4:47-58
96. Morrison LA, Lukacher AE, Braciale VL, Fan DP, Braciale TJ 1986 Differences in antigen presentation to MHC class I- and class II-restricted influenza virus specific cytolytic T lymphocyte clones. J Exp Med 163:903-921
97. + class I-restricted antiviral cytotoxic T cells in vivo. J Virol 66:3661-3668
98. Moskophidis D, Lechner F, Pircher HP, Zinkernagel RM 1993a Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758-761
99. + T cells. Eur J Immunol 23:3306-3311
100. Moskophidis D, Lechner F, Hengartner H, Zinkernagel RM 1994 MHC class I and non MHC-linked capacity for generating an antiviral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice. J Immunol 152:4976-4983
101. Mosmann TR, Coffman RL 1989 TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173
102. Muller D, Koller BH, Whitton JL, LaPan KE, Brigman KK, Frelinger J A 1992 LCMV-specific, class II-restricted cytotoxic T cells in β2-microglobulin-deficient mice. Science 255:1576-1578
103. Müller U, Steinhoff U, Reis LFL et al 1994 Functional role of type I and type II interferons in antiviral defense. Science 264:1918-1921
104. Murphy BR, Channock RM1990 Immunisation against viruses. In: Fields BN, Knipe DM (eds) Fields virology, 2nd edn. Raven, New York, p 469-502
105. Nossal GJV, Ada GL 1971 Antigens, lymphoid cells and the immune response. Academic Press, New York
106. Odermatt B, Eppler M, Leist TP, Hengartner H, Zinkernagel RM 1991 Virus-triggered acquired immunodeficiency by cytotoxic T-cell dependent destruction of antigen-presenting cells and lymph follicle structure. Proc Natl Acad Sci USA 88:8252-8256
107. Oehen S, Hengartner H, Zinkernagel RM 1991 Vaccination for disease. Science 251:195-198
108. Gehen S, Waldner HP, Kündig T, Hengartner H, Zinkernagel RM 1992 Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J Exp Med 176:1273-1281
109. Ohashi PS, Oehen S, Bürki K et al 1991 Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305-317
110. Ohno S, Matsunaga T, Epplen JT, Hozumi T 1980 Interaction of viruses and lymphocytes in evolution, differentiation and oncogenesis. Progr Immunol 4: 577-598
111. Oldstone MBA, Dixon FJ 1967 Lymphocytic choriomeningitis: production of anti-LCM antibody by "tolerant" LCM-infected mice. Science 158:1193-1195
112. Osmond DG 1986 Population dynamics of bone marrow B lymphocytes. Immunol Rev 93:103-124
113. Palese P, Young JF 1982 Variation of influenza A,B, and C viruses. Science 215:1468-1474
114. Parish CR 1972 The relationship between humoral and cell-mediated immunity. Immunol Rev 13:35-66
115. Paul WE 1993 Fundamental immunology. Raven, New York
116. Peters M, Vierling J, Gershwin ME, Milich D, Chisari FV, Hoofnagle JH 1991 Immunology and the liver. Hepatology 13:977-994
117. Phillips RE, Rowland-Jones S, Nixon DF et al 1991 Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354:453-459
118. Pircher HP, Moskophidis D, Rohrer U, Bürki K, Hengartner H, Zinkernagel RM 1990 Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346:629-633
119. Planz O, Bilzer T, Sobbe M, Stitz L 1993 Lysis of major histocompatibility complex class I-bearing cells in borna disease virus-induced degenerative encephalopathy. J Exp Med 178:163-174
120. Porter P 1972 Immunoglobulins in bovine mammary sections: quantitative changes in early lactation and absorption by the neonatal calf. Immunology 23:225-237
121. Rajewsky K 1989 Evolutionary and somatic immunological memory. Prog Imm 7:397-403
122. Rajewsky K, Fürster I, Cumano A 1987 Evolutionary and somatic selection of the antibody repertoire in the mouse. Science 238:1088-1094
123. Ramsay AJ, Ruby J, Ramshaw IA 1993 The case for cytokines as effector molecules in the resolution of virus infection. Immunol Today 14:155-157
124. Reiner SL, Wang Z-E, Hatam F, Scott P, Locksley RM 1993 Th1 and Th2 cell antigen receptors in experimental leishmaniasis. Science 259:1457-1460
125. Rocha B, von Boehmer H 1991 Peripheral selection of the cell repertoire. Science 251:1225-1228
126. Rock KL, Gamble S, Rothstein L 1990 Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science 249:918-921
127. Roost HP, Charan S, Zinkernagel RM 1990 Analysis of the kinetics of antiviral memory T help in vivo: characterization of short lived cross-reactive T help. Eur J Immunol 20:2547-2554
128. Roost HP, Bachmann MF, Haag A et al 1995 Early high-affinity neutralizing antiviral IgG responses without further overall improvements of affinity. Proc Natl Acad Sci USA 92:1257-1261
129. Rosenberg ZF, Fauci AS 1989 The immunopathogenesis of HIV infection. Adv Immunol 47:377-431
130. 2+-independent T cell mediated cytotoxicity. J Exp Med 177:195-200
131. + T cells is dependent on interferon-γ. Lymphokine Cytokine Res 10:353-358
132. + cytotoxic T lymphocytes in mice. Eur J Immunol 22:759-766
133. Schirmbeck R, Melber K, Mertens T, Reimann J 1994 Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen. Eur J Immunol 24:1088-1096
134. Schwartz RH 1990 A cell culture model for T lymphocyte clonal anergy. Science 248:1349-1356
135. Smith TJ, Olson NH, Cheng RH et al 1993 Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody. J Virol 67:1148-1158
136. Speiser DE, Kyburz D, Stübi U, Hengartner H, Zinkernagel RM 1992 Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. J Immunol 149:972-980
137. Sprent J 1994 T and B memory cells. Cell 76:315-322
138. Sprent J, Gao EK, Webb SR 1990 T cell reactivity to MHC molecules: immunity versus tolerance. Science 248:1357-1363
139. + T cell-mediated cytotoxicity. J Immunol 152:1127-1133
140. Stevens JG, Cook ML 1971 Latent herpes simplex virus in spinal ganglia of mice. Science 173:843-845
141. Suda T, Takahashi T, Golstein P, Nagata S 1993 Molecular cloning and expression of the Fas ligand, a novel member of the tumour necrosis factor family. Cell 75:1169-1178
142. Swain SL 1983 T cell subsets and the recognition of MHC class. Immunol Rev 74:129-142
143. Sykulev Y, Brunmark A, Jackson M, Cohen RJ, Peterson PA, Eisen HN 1994 Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity 1:15-22
144. Tew JG, Kosco MH, Burton GF, Szakal AK 1990 Follicular dendritic cells as accessory cells. Immunol Rev 117:185-212
145. Theofilopoulos AN, Dixon FJ 1979 The biology and detection of immune complexes. Adv Immunol 28:89-220
146. Tindle RW, Frazer IH 1994 Immune response to human papilloma viruses and the prospects for human papilloma virus-specific immunisation. Curr Opin Microbiol Immunol 186:217-252
147. von Pirquet C 1908 Das Verhalten der kutanen Tuberkulinreaktion während den Masern. Deutsche Medizinische Wochenschrift 34:1279-1300
148. Wagner RR (ed) 1987 The rhabdoviruses. Plenum, New York
149. Waters JA, Kennedy M, Voet P et al 1992 Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J Clin Invest 90:2543-2547
150. Webb S, Morris C, Sprent J 1990 Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63:1249-1256
151. Weber S, Traunecker A, Oliveri F, Gerhard W, Karjalainen K 1992 Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor. Nature 356:793-796
152. Webster RG, Laver WG, Air GM, Schild GC 1982 Molecular mechanisms of variation in influenza viruses. Nature 296:115-121
153. Weill J -C, Reynaud C-A 1987 The chicken B cell compartment. Science 238:1094-1098
154. Wheelock EF 1965 Interferon-like virus inhibitor produced in human leukocytes by phytohemagglutinin. Science 149:310-313
155. Widmann C, Maryanski JL, Romero P, Corradin G 1991 Differential stability of antigenic MHC class I-restricted synthetic peptides. J Immunol 147:3745-3751
156. Wu-Hsieh B, Howard DH, Ahmed R 1988 Virus-induced immunosuppression: a murine model of susceptibility to opportunistic infection. J Infect Dis 158:232-235
157. Zazopoulos E, Haseltine WA 1993 Effect of nef alleles on replication of human immunodeficiency virus type 1. Virology 194:20-27
158. Zheng LM, Liu CC, Ojcius DM, Young JD 1991 Expression of lymphocyte perform in the mouse uterus during pregnancy. J Cell Sci 99:317-323
159. Zinkernagel RM 1990 Antiviral T-cell memory? Curr Opin Microbiol Immunol 159:65-77
160. Zinkernagel RM 1996 Immunology taught by viruses. Science 271:173-178
161. Zinkernagel RM, Althage A 1977 Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled. J Exp Med 145:644-651
162. Zinkernagel RM, Doherty PC 1979 MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T cell restriction-specificity, function and responsiveness. Adv Immunol 27:52-142
163. Zinkernagel RM, Hengartner H 1994 T cell mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. Immunol Today 15:262-268
164. Zinkernagel RM, Althage A, Adler B et al 1977 H-2 restriction of cell-mediated immunity to an intracellular bacterium. Effector T cells are specific for Listeria antigen in association with H-21 region coded self-markers. J Exp Med 145:1353-1367
165. Zinkernagel RM, Hengartner H, Stitz L 1985 On the role of viruses in the evolution of immune responses. Br Med Bull 41:92-97
166. Zinkernagel RM, Haenseler E, Leist TP, Cerny A, Hengartner H, Althage A 1986 T cell mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. J Exp Med 164:1075-1092
167. Zinkernagel RM, Moskophidis D, Kündig T, Oehen S, Pircher HP, Hengartner H 1993 Effector T cell induction and T cell memory versus peripheral deletion of T cells. Immunol Rev 131:1-25